The cytostatic potential of twenty antibiotic agroclavines has been examined in the L5178y mouse lymphoma cell system. Twelve of these compounds are described for the first time. It is shown that the substituent at N-1 of agroclavine is very important whereas the substituent at N-6 is of less influence if it is not hydrogen.
Incorporation studies in the presence of 1-propylagroclavine suggest that DNA synthesis in the lymphoma cells is inhibited.
The effect on the corresponding [3H]thymidine incorporation in murine spleen lymphocytes is comparably low. Neither a significant change of mRNA efflux nor of DNA polymerase a and B activities was caused. The mechanism of action seems to be a fundamentally new one for ergoline compounds as interactions with a-adrenoceptors, dopamine and 5-hydroxytryptamine receptors are not involved.
Clavines are alkaloids of the 8-methylor 8-hydroxymethylergoline type which are produced by fungi of the genera Claviceps, Aspergillus and Penicillium and by certain genera of the plant family Convolvulaceael).
As we were able to show, some natural clavines and their derivatives possess remarkable antibiotic activity against a series of pathogenic and nonpathogenic bacteria2-4) and even against yeasts4,5). Initial work indicated that these compounds are potent cytostatic agents in the L5178y mouse lymphoma cell system6,7).
These findings prompted us to investigate structure/activity relationships with the aim of developing the clavines as antitumor agents.
In the present contribution the molecule of the most active natural compound, agroclavine (1) , discovered in the early fifties in wild grass ergot by ABE8), was varied by substitution at N-1
and N-6 in order to establish homologous series for testing. Fig. 1 . Structure of agroclavines. For R1 r H and R2 r CH3 see Table 4 .
Agroclavine (1) R1=H, R2=CH3
Materials and Methods
Agroclavine and Its Derivatives
Agroclavine (1) was isolated from surface cultures of Claviceps strain 47a. The 1-alkyl derivatives 2-10 (see Table 4 ) were prepared by alkylation of 1 with potassium and alkyl iodide in NH3 as already Table 2 . Data on semi-synthetic 6-alkyl 6-noragroclavines.
Compounds 1417 were obtained as free bases, compound 13 was obtained as (-)-di-O,O' ptoluoyl hydrogen tartrate; in consequence the data refer to the salt for 13 and to the free base for 14-17. For structure of the compounds see Table 4 . Table 3 . Data on semi-synthetic 1-pentyl-6-noragroclavines.
All compounds were obtained as free bases (yellowish to colorless oils); for structure see Table 4 . IR vKBrmax (cm-1) described previously for compounds 2-5 and 9°9,10). For data on the new compounds 6-8 and 10, see Table 1 . Compound 11 was obtained from 1 by means of the cyanogen bromide method10). The 6-alkyl 6-nor derivatives 12-17 were prepared by alkylation of 11 with alkyl iodide in N,N-dimethylformamide/K2CO3 as already described for 1210). For data on the new compounds 13-17, see Table  2 . Compounds 1820 were obtained by combination of these methods; for data see Table 3 .
Other Cell Growth Inhibition Studies L5178y mouse lymphoma cells11) were grown in EAGLE'S minimum essential medium, supplemented with 10% horse serum in roller tube cultures12). Dose-response experiments were performed as described13, 14) .
The purity of the ergoline compounds was higher than 98 %, as determined by chromatographic methods as well as by elementary analysis. For preparation of the test solutions 10 mg of the compounds were dissolved in 0.2 g dimethyl sulfoxide; afterwards 100 ml sterilized 0.05 % aqueous sodium tartrate solution (pH about 7.25) were added. Equimolar concentrations of tartrate with addition of dimethyl sulfoxide were taken as controls.
Incorporation Studies Five ml suspensions (100,000 cells/m1) of exponentially growing L5178y cells were incubated for 24 hours with 1-propylagroclavine (4). During the last 2 hours of incubation the radioactively labeled precursors 10 uCi [3H]thymidine (dThd), 10 uCi [3H]uridine (Urd) or 10 uCi [3H]phenylalanine (Phe) were added. Samples of 1 ml were analyzed for cell concentration and for acid-insoluble radioactivity15).
Determination of Mitogenic Effects In Vitro
Spleen lymphocytes were prepared from 5-6 weeks old male outbread NMRI mice. The cells were dissociated mechanically be squeezing the tissue through an 80 steel mesh screen. Erythrocytes were removed from the single cell suspension by NH4Cl-treatment.
The spleen cells, containing macrophages, were suspended in RPMI 1640 medium, supplemented with 20% fetal calf serum, at a density of 1.5 x 107 cells/ml. 5 x 105 cells each were placed into a final volume of 200 ul in cups of sterile flatbottomed microtitration plates (Costar No. 3596). The assays were cultured in a fully humidified atmosphere of 5 % CO2 and air at 37°C. Where indicated 2 ug/ml of ConA or 20 ug/ml of LPS were added to the cultures. The lymphocytes were cultivated for 72 hours; 18 hours before the end of the experiment 0.2 uCi of [3H]dThd was added to each cup. Incorporation of [3H]dThd into DNA was determined as described15).
Each experiment was done in quadriplicate. The incorporation rate of [3H]dThd in the absence of mitogens was 39,750±2,600 cpm/5 x 105 cells >< 18 hours and in the presence of 2 ug ConA/ml or 20 ug LPS/ml 127,400±9,350 and 134,550±9,800 cpm/5 x 105 cells x 18 hours, respectively. The ED50 concentrations causing a 50% reduction of [3H]dThd incorporation were estimated by logit regression14). The blastogenic index expresses the ratio between the counts per minute of [3H]dThd incorporation into lymphocytes incubated with the mitogen and incorporation with media alone.
DNA Polymerase Assay DNA polymerase a and B were isolated from L5178y mouse lymphoma cells16) and assayed as described17). Four parallel determinations were performed per value given. The standard deviations did not exceed 12%.
Measurement of RNA Efflux RNA efflux experiments were performed with nuclei, isolated from L5178y mouse lymphoma cells. Prior to this isolation, the cells were incubated for 2 hours in the presence of [3H]Urd. The isolated nuclei were incubated for up to 30 minutes in the presence of an ATP-containing medium and the agro-clavine derivative.
The RNA released during this period of time was collected by trichloroacetic acid precipitation. All experimental details were given previously18) Table 4 . Influence of the substituent at N-1 and N-6 of agroclavine on the cytostatic activity (L5178y mouse lymphoma cell system). Compound In the present study the cytostatic potential of twenty clavines has been examined; among them nine belong to the 1-alkyl agroclavine series and seven are 6-alkyl 6-noragroclavines, agroclavine included.
The remaining compounds are 6-noragroclavine (11) and three clavines with structural variations in position 1 and position 6 (compounds [18] [19] [20] . Twelve of these ergolines are described for the first time (see Tables 1 -3 ).
Structure/Activity Relationships Table 4 compares the ability of the natural alkaloid agroclavine (1) and its derivatives to inhibit growth of L5178y mouse lymphoma cells in vitro. 1-Alkylation (compounds 2-10) significantly augmented the cytostatic effect. Those homologs which bear a three to six carbon atoms membered straight-chain substituent at N-1 (compounds 4-7) were highly effective, giving 50% inhibition at a concentration of 0.87 to 1.6 uM. Four and six membered branched-chain substituted agroclavines (compounds 9 and 10) showed reduced activity compared with their straight-chain isomers.
Removal of the methyl group at N-6 of compound 1 resulted in a marked loss of activity (compound 11). Re-alkylation at N-6 with C2 -C7 membered straight-chain substituents led again to remarkably active compounds (12) (13) (14) (15) (16) (17) . Analogous removal of the methyl group at N-6 of compound 6 however, yielding 1-pentyl-6-noragroclavine (19) , caused only a moderate reduction in cytostatic activity (ED50 concentration of 6 and 19: 0.87 and 1.4 uM, respectively). Re-alkylation at N-6 with the C3-membered straight-chain substituent, yielding 1-pentyl-6-propyl-6-noragroclavine (20) , had almost no effect on the proliferation inhibiting potency (ED50 concentration of 20: 1.3 uM). The experiments were performed in the absence of mitogens (0), or in the presence of 2 µg ConA/ ml (0), or in the presence of 20 ug LPS/ml (A). The incorporation is given in percent (controls: 100%). ---, ED50 value.
Influence of 1-Propylagroclavine on the Synthesis of Macromolecules in L5178y Cells
As an approximative measure of the effect of 1-propylagroclavine (4) on the synthesis of macromolecules in intact cell system the changes of the incorporation rates of [3H]dThd into DNA, [3H]Urd into RNA, and [3H]Phe into protein were determined. Compound 4 inhibited strongly DNA synthesis (ED50 concentration 1.4 uM, 100,000 cells/ml), while RNA and protein synthesis are only slightly affected (Fig. 2) . It is interesting to note that the reduction of cell growth by 50% (Table 4; Compound 4 was tested for its effect on RNA efflux from isolated nuclei as described under "Materials and Methods". In the presence of 2.5 mm ATP in the incubation medium 548 ± 45 dpm of acid-precipitable radioactivity was released from 108 nuclei during an incubation period of 30 minutes. Addition of 0.1 -10 uM of compound 4 was determined to cause no significant change of the RNA efflux rate. at N-1 may be useful depending on the chain length of the alkyl group, with increasing activity until C5 and then with decreasing values for compounds with a substituent > C5. The corresponding chain elongation of the existing methyl group at N-6 of 1 does not influence cytostatic potency to a comparable extent.
It is true that C4-alkylation at N-6 of 11 increases potency approximately 2-fold compared with 1 and more than 5-fold compared with 11, but all members of the 6-alkyl 6-nor series (12) (13) (14) (15) (16) (17) are less active than the C2-C6-alkylated N-1-substituted compounds 3-7. Furthermore, there are some fluctuations within the 6-alkyl 6-nor series; compound 15 (C5) is less active than 14 (C4), but further increase of the alkyl substituent (C6, C7) again leads to more active compounds (16, 17) . The N-6-alkylated clavines of Table 4 (1, 12-17) are active within a relatively narrow ED50 concentration range of 2.9-7.1 uM compared with their N-1-analogs (2-10), which possess a range of activities between 0.87 and 5.2 uM indicating that the substituent at N-1 is of more influence and importance.
Comparison of the influence of straight-chain substituents at N-1 with analogous branched-chain groups show that chain branching is of disadvantage; compounds 5 and 7 are 3-and 2-fold more potent than 9 and 10, respectively. 6-Noragroclavine (11) with its secondary and basic N-6, an inactive compound in contrast to the tertiary and basic N-6 compounds 1 and 12-17, can be transformed into a potent cytostatic agent by C5-alkylation at N-1 (compound 19, ED50 concentration: 1.4 uM), thus proving that N-6 does not necessarily have to be tertiary. N-6 does not even need basic properties; the 6-cyano-6-nor derivative 18 is also active (ED50 concentration: 4.5 uM) in spite of the fact that the cyano substituent causes the loss of N-6 basicity. But 18 is C5-alkylated at N-1, too; the corresponding compound not substituted at N-1 (6-cyano-6-noragroclavine) is inactive.
In conclusion the combination of these results with those of previously published papers6,7,19) now allows a generalization with respect to the influence of the substituent at the non-basic N-1 (indole nitrogen) of clavines; 1-alkylation, especially C3-C5, does not only increase the potency of already active clavines but also transforms inactive clavines into cytostatically very active compounds, neutralizing the negative influence of the 8-hydroxymethyl substituent compared with the 8-methyl substituent7, of the secondary state of N-6 in 6-norclavines compared with tertiary 6-alkyl 6-norclavines (see also ref 19) , and of the N-6 cyano group compared with N-6 alkylated analogs.
Like 1-propylfestuclavine6), 1-propylagroclavine (4) was also shown to be a potent and preferential inhibitor of DNA synthesis. It has now been clarified that this inhibition is not due to a direct effect on DNA polymerase a or Q. Preliminary studies to determine the target, which causes the reduction of DNA synthesis, suggest that agroclavine (1) interferes with the state of organization of the nuclear reticulum (unpublished). RNA synthesis and nucleo-cytoplasmic efflux of mRNA are not affected at cytostatic concentrations.
It is known that natural clavines interact, like the lysergic acid amides, with dopamine (DA) and 5-hydroxytryptamine (5-HT) receptors and with a lower affinity even with a-adrenoreceptors20). Thus an obvious mechanism of action could involve the interaction with one of these receptors for the inhibition of proliferation, too. Nevertheless there is evidence indicating that this does not seem to be the case.
The following facts led us to the assumption that a mechanism involving interaction with DA receptors is improbable:
(1) DA itself was not active in our cell system (ED50 concentration: 13.2 uM); (2) sulpiride, a DA antagonist, was also inactive (33.3 uM); (3) the combination of sulpiride and compound 4 did not show any change in the cytostatic activity compared with 4 alone; (4) simple lysergic acid amides (lysergic acid amide, isolysergic acid amide, LSD, methylergometrine) are well known as DA agonists and antagonists20), but they were not cytostatic; (5) on the other hand it is true that agroclavine also shows dopaminergic properties, but N-1-substituted ergolines, e.g. methysergide and methergoline, do not20'21) (N-1-alkylated agroclavines, however, are very potent cytostatic agents); (6) agroclavine is less active as an inhibitor of prolactin release than elymoclavine21,22), but elymoclavine is cytostatically inactive. From all this evidence we conclude that the agroclavines are not working by the same mechanism as the ergoline compounds which are useful against prolactin-dependent tumors, e.g. bromocriptine, namely via DA receptors.
The following facts led us to the assumption that a mechanism of action involving interactions with 5-HT receptors is also improbable though even 1-alkyl agroclavines are 5-HT antagonists:
(1) Serotonin itself was absolutely inactive (ED,,, concentration: >60 uM); (2) simple lysergic acid amides are well known as both 5-HT agonists and antagonists20), but they were inactive as cytostatics.
Similar considerations lead us to conclude that interactions with a-adrenoreceptors are also not involved. Simple lysergic acid amides and even the ergopeptine type alkaloid ergotamine are cytostatically inactive or weakly active (ergotamine: ED50 concentration 11.3 uM, ergometrine > 30 uM) though interacting with a-adrenoreceptors and DA/5-HT receptors.
Finally the fact, that cytostatically active clavines also show antibiotic properties against bacteria and yeasts, could be further evidence against the participation of catecholamine or serotonin receptors in the mechanism of action; as far as we know these receptors do not exist in microorganisms. The cytostatic potential of the agroclavines is relatively high; under otherwise identical conditions well-known cytostatic antibiotics like bleomycin, doxorubicin (adriamycin), and daunorubicin (daunomycin) reduce cell proliferation by 50% at 1.0, 1.2 and 1.9 uM, respectively.
Of potential importance for future application is the finding that 1-propylagroclavine (4) causes a 50% inhibition of the [3H]dThd incorporation rate in murine spleen lymphocytes only at concentrations as high as 10-23 uM, depending on the presence of mitogens. In comparison, this inhibition was caused by the same compound in the L5178y cell system at 1.4 uM.
